Table 2. Characteristics of adult subjects with low or high UCP1 expression levels in AT.
| SUBCUTANEOUS SAMPLES | VISCERAL SAMPLES | |||||
|---|---|---|---|---|---|---|
| Low UCP1 | High UCP1 | p-value | Low UCP1 | High UCP1 | p-value | |
| N | 48 | 48 | 48 | 48 | ||
| female/male [n] | 35/13 | 29/19 | 0.194 | 38/10 | 28/20 | 0.027 |
| Age [years] | 47.3±1.6 | 53.1±2.2 | 0.033 | 49.7±1.7 | 51.1±1.6 | 0.561 |
| (26.2–73.0) | (24.5–86.8) | (26.4–80.5) | (24.5–77.2) | |||
| BMI [kg/m²] | 48.1±1.5 | 43.7±2.1 | 0.091 | 45.2±1.3 | 43.3±1.7 | 0.370 |
| (18.8–73.6) | (19.0–88.8) | (18.8–59.3) | (19.2–67.4) | |||
| UCP1expression | 0.6±0.05 | 278.5±68.3 | <0.001 | 0.6±0.05 | 372.0±90.2 | <0.001 |
| (0.0–1.2) | (42.4–2970.7) | (0.0–1.105) | (58.3–2864.9) | |||
Data are given as mean ± SEM (range). For gender, statistical significance was analysed by chi square test. Statistical significance for differences between groups was determined by Students t-test. Significant p-values are indicated in bold. BMI, body-mass index.